Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 190-194, 2004. First published November 18, 2003; 10.1373/clinchem.2003.019216
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2003.019216v1
50/1/190    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lo, S. F.
Right arrow Articles by Ashwood, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lo, S. F.
Right arrow Articles by Ashwood, E. R.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Pediatric Clinical Chemistry
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2004;50:190-194.)
© 2004 American Association for Clinical Chemistry, Inc.

General Clinical Chemistry

Performance of Bilirubin Determinations in US Laboratories—Revisited

Stanley F. Lo1,2,a, Basil T. Doumas1,2 and Edward R. Ashwood3

1 Reference Standards Laboratory, Department of Pathology and Laboratory Medicine, Children’s Hospital of Wisconsin, Milwaukee, WI.
2 Department of Pathology, Medical College of Wisconsin, Milwaukee, WI.
3 ARUP Laboratories, Department of Pathology, University of Utah, Salt Lake City, UT.

aAddress correspondence to this author at: Reference Standards Laboratory, Children’s Hospital of Wisconsin, 9000 W. Wisconsin Ave., Milwaukee, WI 53226. Fax 414-266-2779; e-mail slo{at}mail.mcw.edu.

Background: The diagnosis and management of hyperbilirubinemia in the newborn requires accurate and precise bilirubin determinations. We evaluated the current status of bilirubin measurements in US laboratories by examining data submitted by laboratories participating in the College of American Pathologists (CAP) Neonatal Bilirubin (NB) and Chemistry (C) Surveys.

Methods: We analyzed specimens from the CAP NB and C Surveys by the reference method for total bilirubin in three laboratories. The reference method bilirubin values were compared with bilirubin values reported by Survey participants.

Results: The imprecision (CV) for all instruments combined (CAP-All Instruments) ranged from 4.7% to 5.6% at the bilirubin concentrations tested. The CVs of the four most commonly used instruments were smaller, ranging from 1.9% to 4.5%. Differences between bilirubin values by the reference method and mean values from the four most common instruments ranged from -21.6% to 10.9%. When the same specimens from the NB Surveys were used in the C Surveys, the Vitros values were strikingly different from those of the NB Surveys. The use of different methods in the NB and C Surveys coupled with the presence of a nonhuman protein base and ditaurobilirubin (DTB) in the Survey specimens accounted for the discrepant results.

Conclusions: The evaluation of accuracy is impossible from the CAP Surveys because the specimens consist of bovine serum containing a mixture of unconjugated bilirubin and DTB. For the evaluation of accuracy, we recommend that Survey specimens consist of human serum enriched with unconjugated bilirubin.




The following articles in journals at HighWire Press have cited this article:


Home page
 Ann Clin BiochemHome page
J. M Kirk
Neonatal jaundice: a critical review of the role and practice of bilirubin analysis
Ann Clin Biochem, September 1, 2008; 45(5): 452 - 462.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. F. McDonagh
Ex Uno Plures: The Concealed Complexity of Bilirubin Species in Neonatal Blood Samples
Pediatrics, September 1, 2006; 118(3): 1185 - 1187.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
R Keren, V K Bhutani, X Luan, S Nihtianova, A Cnaan, and J S Schwartz
Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches
Arch. Dis. Child., April 1, 2005; 90(4): 415 - 421.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. K. Stevenson, R. J. Wong, and H. J. Vreman
Reduction in Hospital Readmission Rates for Hyperbilirubinemia Is Associated with Use of Transcutaneous Bilirubin Measurements
Clin. Chem., March 1, 2005; 51(3): 481 - 482.
[Full Text] [PDF]

Home page
 PediatricsHome page
Subcommittee on Hyperbilirubinemia
Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
Pediatrics, July 1, 2004; 114(1): 297 - 316.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.